With the FDA taking their time reviewing Pfizer’s vaccine EUA and getting beaten by the UK to the punch, , I am not encouraged that the FDA will find ways to speed up EUA for Leronlimab. Hahn’s reasoning was that they had to make absolutely sure the vaccine is going to work because they are worried about the public’s perception of a process that was “sped up” and would appear to the public as cutting corners, thus , limiting acceptance of the drug by the public. This is the logic we are dealing with in an agency with 17,000 “lifers “ as employees. So let’s hope we hit full enrollment very soon on Cd12 which I believe will be in the next two weeks and get this thing towards approval !